ArticleThe Journal of biological chemistry2019

A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice.

Shuyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.